TNF and breast benign neoplasm: The diametrically opposed results of the two studies may be attributed to differences in the control populations, namely healthy individuals versus patients with benign breast tumors, on the one hand, and on the other hand, to the possibility that the level of TNF-α may be influenced by other immune cells, such as Th1 cells.